Skip to main content

REVIEW article

Front. Immunol.

Sec. Nutritional Immunology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1563504

This article is part of the Research Topic Impact of Dietary Nanoparticles on Food Allergy Development and Immune Response View all articles

Inorganic Dietary Nanoparticles in Intestinal Barrier Function of Inflammatory Bowel Disease: Allies or Adversaries?

Provisionally accepted
Duo Luo Duo Luo 1Guifang Luo Guifang Luo 1Haoming Xu Haoming Xu 1Kangbao Li Kangbao Li 1*Zhaotao Li Zhaotao Li 2*Cong Zhang Cong Zhang 2*
  • 1 Guangzhou First People's Hospital, Guangzhou, Guangdong Province, China
  • 2 The First People's Hospital of Foshan, Foshan, China

The final, formatted version of the article will be published soon.

    Inorganic dietary nanoparticles (IDNPs) are frequently utilized as food additives and in packaging, resulting in their exposure becoming a substantial yet often overlooked concern for patients with inflammatory bowel disease (IBD). Considering that impaired intestinal barrier function plays a central role in the pathogenesis of IBD, this review concentrates on the roles and mechanisms of IDNPs in the intestinal barrier (physical, chemical, biological, and immune barriers) of IBD patients.Previous studies have shown that different types of nanoparticles have varying effects on animals in diverse states. In this context, factors such as the source, size, shape, dosage, and duration of action of the nanoparticles, as well as the species, gender, dietary habits, and age of the animals, significantly influence research outcomes. Future studies should undertake more comprehensive explorations into the effects and mechanisms of IDNPs with diverse sources and properties in IBD patients.

    Keywords: Inorganic dietary nanoparticles, inflammatory bowel disease, intestinal barrier, Immune barrier, Biological barrier

    Received: 20 Jan 2025; Accepted: 24 Mar 2025.

    Copyright: © 2025 Luo, Luo, Xu, Li, Li and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Kangbao Li, Guangzhou First People's Hospital, Guangzhou, 510180, Guangdong Province, China
    Zhaotao Li, The First People's Hospital of Foshan, Foshan, China
    Cong Zhang, The First People's Hospital of Foshan, Foshan, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more